Caffey Disease: an Unlikely Collagenopathy

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Caffey disease: an unlikely collagenopathy Francis H. Glorieux J Clin Invest. 2005;115(5):1142-1144. https://doi.org/10.1172/JCI25148. Commentary Infantile cortical hyperostosis (also known as Caffey disease) is characterized by hyperirritability, acute inflammation of soft tissues, and profound alterations of the shape and structure of the underlying bones, particularly the long bones, mandible, clavicles, or ribs. In this issue of the JCI, Gensure et al. undertook fine mapping of the genetic locus for this disease in a large kindred of individuals with the autosomal dominant form of the condition. The authors found a novel missense mutation in COL1A1, the gene encoding the α1 chain of type I collagen, in all affected individuals in 3 discrete pedigrees. This is a surprising finding, as all other reported mutations affecting the synthesis of type I collagen lead to conditions such as osteogenesis imperfecta and Ehlers-Danlos syndrome, in which quantitative or qualitative defects in type I collagen synthesis give rise to bone fragility and/or connective tissue hyperextensibility. The deleterious effect of the mutation on collagen fibril morphology is demonstrated; however, the precise functional link between the reported missense mutation and the localized inflammation and hyperostosis seen in Caffey disease awaits future studies. Find the latest version: https://jci.me/25148/pdf commentaries apolipoprotein B-100 in NIDDM. Diabetologia. 120:1183–1192. 17. Schattenberg, J.M., Wang, Y., Singh, R., Rigoli, 38:959–967. 16. Powell, E.E., et al. 1990. The natural history of R.M., and Czaja, M.J. 2005. Hepatocyte CYP2E1 15. Sanyal, A.J., et al. 2001. Nonalcoholic steato- nonalcoholic steatohepatitis: a follow-up study of overexpression and steatohepatitis lead to hepatitis: association of insulin resistance and forty-two patients for up to 21 years. Hepatology. impaired hepatic insulin signaling. J. Biol. Chem. mitochondrial abnormalities. Gastroenterology. 11:74–80. 280:9887–9894. Caffey disease: an unlikely collagenopathy Francis H. Glorieux Departments of Surgery, Pediatrics, and Human Genetics, McGill University, and Genetics Unit, Shriners Hospital for Children, Montréal, Quebec, Canada. Infantile cortical hyperostosis (also known as Caffey disease) is character- Bone lesions ized by hyperirritability, acute inflammation of soft tissues, and profound The radiographic features of ICH evolve alterations of the shape and structure of the underlying bones, particularly in stages. Hyperostoses develop on the the long bones, mandible, clavicles, or ribs. In this issue of the JCI, Gensure outer cortical surface, expand, and then et al. undertook fine mapping of the genetic locus for this disease in a large remodel by resorption either at the exter- kindred of individuals with the autosomal dominant form of the condition. nal surface or at the endocortical surface. The authors found a novel missense mutation in COL1A1, the gene encod- In the latter case, there is an expansion of ing the α1 chain of type I collagen, in all affected individuals in 3 discrete the medullary cavity and the cortex is thin pedigrees (see the related article beginning on page 1250). This is a surpris- (Figure 2B). Epiphyses and metaphyses are ing finding, as all other reported mutations affecting the synthesis of type I typically not involved. Tubular bones may collagen lead to conditions such as osteogenesis imperfecta and Ehlers-Dan- be grossly deformed (Figure 1), with bony los syndrome, in which quantitative or qualitative defects in type I collagen bridges sometimes appearing between synthesis give rise to bone fragility and/or connective tissue hyperextensi- adjacent bones (forearm, ribs). The histol- bility. The deleterious effect of the mutation on collagen fibril morphology ogy of the bone lesions has been described is demonstrated; however, the precise functional link between the reported in detail (3). Such lesions include not only missense mutation and the localized inflammation and hyperostosis seen in subperiosteal new lamellar bone forma- Caffey disease awaits future studies. tion but also evidence of local inflamma- tion. Early on, foci of acute inflammation Infantile cortical hyperostosis (ICH) note that this phase of acute inflamma- are confined in the periosteum; they then — also referred to as Caffey or Caffey-Sil- tion precedes the abnormal thickening of disrupt the periosteal envelope to blend verman disease — was recognized in 1945 cortical bone (hyperostosis) that gives its with contiguous tissues (fasciae, muscle, by Caffey and Silverman (1). The condi- name to the disease. It also subsides long and tendon). In the subacute phase, the tion, later shown to be transmitted as an before the hyperostosis resolves. Some- periosteum reestablishes itself as an entity autosomal dominant trait with incom- times lesions recur suddenly in their orig- with a sheet of fibrous tissue under which plete penetrance, becomes clinically evi- inal sites or in new sites, either during or new subperiosteal bone is formed. In the dent before 5–7 months of life, and the after the subsidence of the swellings that late remodeling stage, signs of inflam- average age at onset is around 9 weeks. appeared at the onset of the disease. This mation disappear, and excess peripheral The initial symptom is general hyperirri- uneven protracted clinical course with bone is removed. tability, with fever and anorexia, quickly unpredictable remissions and relapses is Based on these facts, discussion of the followed by painful, firm soft-tissue one of the most characteristic features of pathophysiology of ICH naturally turns swelling, particularly in the face (cheeks the condition (2). toward a mechanism likely to induce and jaws), the scapular region, and upper and lower limbs. It is usually self-lim- ited, with severe symptoms lasting from 2–3 weeks to 2–3 months. The pattern of distribution of the lesions varies from patient to patient and can be symmetri- cal (Figure 1). Swelling also involves underlying muscle. It is important to Nonstandard abbreviations used: COL1A1, gene encoding the α1 chain of type I collagen; EDS, Ehlers- Danlos syndrome; ICH, infantile cortical hyperostosis; PGE, prostaglandin E. Conflict of interest: The author has declared that no Figure 1 conflict of interest exists. A 6-month-old girl with typical clinical findings of Caffey disease, which appeared at age 7 Citation for this article: J. Clin. Invest. 115:1142–1144 weeks. The painful swelling of soft tissue around the legs (A) is matched by severe involvement (2005). doi:10.1172/JCI200525148. of the tibia and fibula bilaterally (x-radiography, B). Femurs are strikingly unaffected. 1142 The Journal of Clinical Investigation http://www.jci.org Volume 115 Number 5 May 2005 commentaries Figure 2 Schematic illustrating normal and exuberant bone formation. (A) Representation of a growing bone. Growth in length is achieved by endochondral bone formation adding cancellous bone in the metaphyseal area. Gain in diameter comes from subperiosteal new bone apposition by intramem- branous bone formation. The periosteum is an envelope of fibrous connective tissue that is wrapped around diaphyses. The size of the marrow cavity is controlled by a combination of bone apposition and resorption at the endocortical surface. (B and C) In ICH/Caffey disease, hyperostosis develops by exacerbated subperiosteal intramembranous bone formation triggered by local inflammation (left side of B and C). In the remodeling phase, the excess of bone tissue is resorbed either at the endocortical surface, leading to an expansion of the marrow cavity and a more persistent deformity (right side of B), or at the exocortical surface, with no effect on the size of the marrow cavity (right side of C). local inflammation. Such a hypothesis collagen (6). The careful and elegant work the triple-helical domain. Because of its received strong support from a report by of Gensure et al. has established a strong small size, it packs tightly at the center of Ueda et al. (4) demonstrating that admin- linkage between the ICH phenotype and the helix and confers stability. A mutation istration of prostaglandin E (PGE) in the COL1A1 locus on chromosome 17q21 affecting a Gly residue will thus have an infants with ductus-dependent cyanotic in 3 discrete pedigrees from Australia and impact on the conformation of the colla- heart disease induced a form of cortical Canada with an autosomal dominant gen molecule, its integration in the tissue hyperostosis that mimics ICH. Two years form of ICH. More importantly, despite (bone, skin, and tendon), and the struc- later, Heyman et al. (5) reported that in 5 the fact that the families were geographi- tural qualities of the tissue. This is the affected children, PGE serum levels were cally dispersed and unrelated, it was case in osteogenesis imperfecta, or brittle significantly elevated and that treatment found that all affected individuals were bone disease, where most mutations with- with indomethacin (an inhibitor of PGE heterozygous for the identical mutation, in COL1A1 are glycine substitutions. The synthesis) rapidly suppressed irritabil- a substitution of Arg by Cys at position severity of the phenotype is determined ity and led to a progressive decrease in 836 (R836C), within the helical domain in part by the pattern of inheritance, the soft-tissue swelling in 6–9 days. Wheth- of the α1 chain of type I collagen. The position of the mutation in the α1 chain, er elevated PGE levels were a cause or a linkage and sequencing data are solid and and the bulkiness of the replacement resi- consequence of the lesions could not be convincing and represent a major step for- due, as it will variably compromise forma- answered. We have made the same obser- ward in the understanding of the pathol- tion and stability of the helix. vations in 3 patients (Glorieux et al., ogy of an elusive disease. In contrast, the R836C mutation iden- unpublished data). One has to now try and understand how tified by Gensure et al. (6) in these ICH a point mutation in a widely distributed patients would not be predicted to have ICH pathophysiology structural protein can initiate the cascade such an effect on the collagen molecule.
Recommended publications
  • Upper Jaw Chronic Osteomyelitis. Report of Four Clinical Cases Osteomielitis Crónica Maxilar

    Upper Jaw Chronic Osteomyelitis. Report of Four Clinical Cases Osteomielitis Crónica Maxilar

    www.medigraphic.org.mx Revista Odontológica Mexicana Facultad de Odontología Vol. 16, No. 2 April-June 2012 pp 105-111 CASE REPORT Upper jaw chronic osteomyelitis. Report of four clinical cases Osteomielitis crónica maxilar. Informe de 4 casos clínicos Alberto Wintergerst Fish,* Carlos Javier Iturralde Espinosa,§ Vladimir de la Riva Parra,II Santiago Reinoso QuezadaII ABSTRACT RESUMEN Osteomyelitis is an infl ammatory bone disease commonly related La osteomielitis es una enfermedad ósea infl amatoria, comúnmente to an infectious origin caused by germs, mainly pyogenic staphy- relacionada a un origen infeccioso por gérmenes piógenos funda- lococcus, and occasionally, streptococci, pneumococci and en- mentalmente estafi lococos y en algunas ocasiones por estreptoco- terobacteriae. Several treatments and classifi cations for osteomy- cos, neumococos y enterobacterias. Se han establecido diversas elitis have been established. These are based on clinical course, clasifi caciones y tratamientos para la osteomielitis, basadas en el pathologic-anatomical or radiologic features, etiology and patho- comportamiento clínico, características anatomo-patológicas, ra- genesis. Chronic osteomyelitis is a complication of non-treated or diográfi cas, etiología y patogenia. La osteomielitis crónica es una inadequately treated acute osteomyleitis. It can also be caused by a complicación de la osteomielitis aguda no tratada, manejada inade- low grade prolonged infl ammatory reaction. This study presents four cuadamente o como una reacción infl amatoria prolongada de bajo cases of maxillary osteomyelitis treated between 2007 and 2009. grado. Se presentan 4 casos de osteomielitis crónica en el maxilar Cases were treated with antimicrobial therapy. Preoperatively, pa- tratadas entre 2007 y 2009 mediante terapia antimicrobiana preo- tients were prescribed Clindamycin, 300 mg every eight hours, Ce- peratoriamente con clindamicina 300 mg, IV cada 8 h y ceftriaxona friaxone, 1 g IV every 12 hours.
  • Osteomalacia and Osteoporosis D

    Osteomalacia and Osteoporosis D

    Postgrad. med.J. (August 1968) 44, 621-625. Postgrad Med J: first published as 10.1136/pgmj.44.514.621 on 1 August 1968. Downloaded from Osteomalacia and osteoporosis D. B. MORGAN Department of Clinical Investigation, University ofLeeds OSTEOMALACIA and osteoporosis are still some- in osteomalacia is an increase in the alkaline times confused because both diseases lead to a phosphatase activity in the blood (SAP); there deficiency of calcium which can be detected on may also be a low serum phosphorus or a low radiographs of the skeleton. serum calcium. This lack of calcium is the only feature Our experience with the biopsy of bone is that common to the two diseases which are in all a large excess of uncalcified bone tissue (osteoid), other ways easily distinguishable. which is the classic histological feature of osteo- malacia, is only found in patients with the other Osteomalacia typical features of the disease, in particular the Osteomalacia will be discussed first, because it clinical ones (Morgan et al., 1967a). Whether or is a clearly defined disease which can be cured. not more subtle histological techniques will detect Osteomalacia is the result of an imbalance be- earlier stages of the disease remains to be seen. tween the supply of and the demand for vitamin Bone pains, muscle weakness, Looser's zones, D. The the following description of disease is raised SAP and low serum phosphate are the Protected by copyright. based on our experience of twenty-two patients most reliable aids to the diagnosis of osteomalacia, with osteomalacia after gastrectomy; there is no and approximately in that order.
  • Osteopetrosis J

    Osteopetrosis J

    Arch Dis Child: first published as 10.1136/adc.46.247.257 on 1 June 1971. Downloaded from Archives of Disease in Childhood, 1971, 46, 257. Osteopetrosis J. S. YU,* R. K. OATES, K. HELEN WALSH, and SUSAN J. STUCKEY From the Department of Child Health, University of Sydney, and Department of Dietetics, Royal Alexandra Hospital for Children, Camperdown, N.S.W., Australia Yu, J. S., Oates, R. K., Walsh, K. H., and Stuckey, S. J. (1971). Archives of Disease in Childhood, 46, 257. Osteopetrosis. The clinical histories of nine children with osteopetrosis are reported. Two of them had the malignant infantile variety of the disease: one died within 3 months of birth and the other has survived 20 months on a regimen of a low calcium intake, cellulose phosphate, and steroids. The beneficial effect of a low calcium intake, in early infancy, is supported by the clinical course in the infant with the malignant variety and in another child with the more benign form of the disease. No calcium balance studies were performed. This study suggests that the active measures outlined may favourably influence the haematological and osteosclerotic course of the disease, pending further know- ledge of its aetiological basis, and more specific therapy. Osteopetrosis or marble bone disease is a rare positive calcium balance with a diet low in calcium metabolic bone disease characterized by dense and with steroids (Morrow et al., 1967). This bones (Albers-Schonberg, 1904; Karshner, 1926). approach to management has been recently criti- copyright. Two varieties have been clearly defined-an cized by Cohen (Children's Hospital Medical infantile progressive disease and a milder benign Center, Boston, 1965).
  • Hematological Diseases and Osteoporosis

    Hematological Diseases and Osteoporosis

    International Journal of Molecular Sciences Review Hematological Diseases and Osteoporosis , Agostino Gaudio * y , Anastasia Xourafa, Rosario Rapisarda, Luca Zanoli , Salvatore Santo Signorelli and Pietro Castellino Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy; [email protected] (A.X.); [email protected] (R.R.); [email protected] (L.Z.); [email protected] (S.S.S.); [email protected] (P.C.) * Correspondence: [email protected]; Tel.: +39-095-3781842; Fax: +39-095-378-2376 Current address: UO di Medicina Interna, Policlinico “G. Rodolico”, Via S. Sofia 78, 95123 Catania, Italy. y Received: 29 April 2020; Accepted: 14 May 2020; Published: 16 May 2020 Abstract: Secondary osteoporosis is a common clinical problem faced by bone specialists, with a higher frequency in men than in women. One of several causes of secondary osteoporosis is hematological disease. There are numerous hematological diseases that can have a deleterious impact on bone health. In the literature, there is an abundance of evidence of bone involvement in patients affected by multiple myeloma, systemic mastocytosis, thalassemia, and hemophilia; some skeletal disorders are also reported in sickle cell disease. Recently, monoclonal gammopathy of undetermined significance appears to increase fracture risk, predominantly in male subjects. The pathogenetic mechanisms responsible for these bone loss effects have not yet been completely clarified. Many soluble factors, in particular cytokines that regulate bone metabolism, appear to play an important role. An integrated approach to these hematological diseases, with the help of a bone specialist, could reduce the bone fracture rate and improve the quality of life of these patients.
  • Spontaneous Healing of Osteitis Fibrosa Cystica in Primary Hyperparathyroidism

    Spontaneous Healing of Osteitis Fibrosa Cystica in Primary Hyperparathyroidism

    754 Gibbs, Millar, Smith Postgrad Med J: first published as 10.1136/pgmj.72.854.754 on 1 December 1996. Downloaded from Spontaneous healing of osteitis fibrosa cystica in primary hyperparathyroidism CJ Gibbs, JGB Millar, J Smith Summar biochemistry showed hypercalcaemia, hypo- A 24-year-old man with primary hyper- phosphataemia, elevated parathyroid hormone, parathyroidism and osteitis fibrosa cystica but normal alkaline phosphatase (table). developed acute hypocalcaemia. Sponta- Radiographs showed improvement in the neous healing of his bone disease was mandibular translucency and resolution of the confirmed radiographically and by correc- phalangeal tuft resorption and subperiosteal tion of the serum alkaline phosphatase. erosion (figures 1B, 2B). Thallium scan of the Hypercalcaemia associated with a raised neck showed no evidence of parathyroid serum parathyroid hormone recurred 90 activity and neck exploration failed to reveal weeks after the initial presentation. Dur- any parathyroid tissue. Venous sampling ing the fourth neck exploration a para- showed no step-up in parathyroid hormone thyroid adenoma was removed, resulting concentration in the neck or chest. Selective in resolution of his condition. Haemor- angiography suggested a parathyroid adenoma rhagic infarction of an adenoma was the behind the right clavicle but two further most likely cause of the acute hypocalcae- explorations revealed only one normal para- mic episode. thyroid gland. Computed tomography (CT) of the neck showed a low attenuation, non- Keywords: primary hyperparathyroidism, osteitis enhancing mass in the right lower pole of the fibrosa cystica, hypercalcaemia thyroid gland. Ultrasonography confirmed a hypo-echoic mass 1.5 x 0.5 cm in the right lobe of the thyroid.
  • Introduction to the Orthopedics

    Introduction to the Orthopedics

    [ Color index : Important | Notes | Extra ] Editing file link ​ ​ ​ ​ ​ ​ ​ ​ Introduction to the Orthopedics Objectives: ★ To explain what Orthopedic is and what conditions will be discussed during this course ★ Explain what we mean by Red Flags ★ List the different causes of orthopedic disease. ★ Describe some of clinical examination tests ★ Introduce titles of Clinical Skills which will be taught during this course. Done by: Rana Albarrak & Lamya Alsaghan ​ Edited By: Bedoor Julaidan ​ Revised by: Dalal Alhuzaimi ​ References: slides + Toronto notes + 433 team + 435 team group A ​ Introduction Orthopedic specialty: ★ Branch of surgery concerned with conditions involving the musculoskeletal system. ​ ​ Orthopedic surgeons use both surgical and nonsurgical means to treat musculoskeletal trauma, spine diseases, sports injuries, degenerative diseases, infections, tumors, and congenital disorders. ★ It includes: bones, muscles, tendons, ligaments, joints, peripheral nerves (peripheral neuropathy ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ of hand and foot), , vertebral column, spinal cord and its nerves. NOT only bones. ​ ​ ​ ​ ​ ​ ​ ★ Subspecialties: General, pediatric, sport and reconstructive (commonly ACL “anterior cruciate ​ ​ ligament” injury), trauma, arthroplasty, spinal surgery, foot and ankle surgery, oncology, hand ​ surgery (usually it is a mixed speciality depending on the center. Orthopedics = up to the wrist joint. ​ Orthopedics OR plastic surgery = from carpal bones and beyond, upper limb (new) elbow & shoulder. ​ ​ ​ ​ ​ will be discussed in details in a separate lectures ​Red Flags: ★ Red Flags =​ warning symptoms or signs = necessity for urgent or different action/intervention. ​ ​ ​ ​ ​ ​ ​ ​ ★ Should always be looked for and remembered. you have to rule out red flags with all emergency ​ ​ ​ cases! Fever is NOT a red flag! Do not confuse medicine with ortho. Post-op day 1 fever is considered normal! ​ ★ There are 5 main red flags: ​ ​ ​ ​ 1.
  • Bone Homeostasis and Pathology

    Bone Homeostasis and Pathology

    Bone Homeostasis and Pathology Instructor: Roman Eliseev Outline: § Bone anatomy and composi<on § Bone remodeling § Factors regulang bone homeostasis § Disorders of bone homeostasis: -Bone loss -Abnormal bone acquisi<on § Methods and Mouse Models Adult Skeleton Axial Skeleton Appendicular Skeleton 206 bones Image from www.pngall.com Adult Bone Architecture Cor<cal bone Marrow cavity Diaphysis Metaphysis Epiphysis Trabecular bone Bone Histology Subchondral bone Trabecular bone Marrow fat Bone marrow Cor<cal bone Bone Composion Bone is a mineralized organic matrix composed of: • Type I collagen and non-collagenous proteins (osteoid) • Hydroxyapate crystals (Ca5(PO4)3(OH)) Osteoblasts Bone Bone-forming cells are osteoblasts (OB) that produce collagen I and deposit HA Bone is Formed by Osteoblasts OBs originate from Bone Marrow Stromal (a.k.a. Mesenchymal Stem) Cells (BMSC) and terminally differen<ate into osteocytes (OT). Wagner et al., PPAR Res., 2010 Bone is Resorbed by Osteoclasts Image from SciencePhotoLibrary Osteoclasts (OC) are bone resorbing mul<nucleated cells that originate from hematopoie<c cells (monocyte/macrophage) Homeostasis = equilibrium (Greek: ὁμοίως + στάσις) Bone Formaon vs Resorp<on = Dynamic Equilibrium (~10% of adult human skeleton is replaced annually) Bone Bone rosorp<on formaon Intact Bone BMSC – bone marrow stromal Blood vessel (a.k.a. mesenchymal stem) cell BMSC OB – osteoblast OT – osteocyte Apoptosis OB (~70%) Lining cells BONE OT TGFb, IGF1, OCN Collagen I Remodeling: Ini<al Phase BMSC – bone marrow stromal (a.k.a. mesenchymal stem) cell Blood vessel HSC OB – osteoblast BMSC OT – osteocyte HSC – hematopoie<c stem cell RANKL, OCP – osteoclast precursor ? m-CSF OCP OB Lining cells BONE OT Remodeling: Resorp<on Pit BMSC – bone marrow stromal (a.k.a.
  • Osteoporosis/Bone Health in Adults As a National Public Health Priority

    Osteoporosis/Bone Health in Adults As a National Public Health Priority

    Position Statement Osteoporosis/Bone Health in Adults as a National Public Health Priority This Position Statement was developed as an educational tool based on the opinion of the authors. It is not a product of a systematic review. Readers are encouraged to consider the information presented and reach their own conclusions. Osteoporosis is a widespread metabolic bone disease characterized by decreased bone mass and poor bone quality. It leads to an increased frequency of fractures of the hip, spine, and wrist. Osteoporosis is a global public health problem currently affecting more than 200 million people worldwide. In the United States alone, 10 million people have osteoporosis, and 18 million more are at risk of developing the disease. Another 34 million Americans are at risk of osteopenia, or low bone mass, which can lead to fractures and other complications. Low bone mass is a growing global health burden, and likely reflects only a small part of the true burden of osteoporosis, given that bone mineral density (BMD) does not indicate other important components of bone strength. Fragility fractures have a morbidity and mortality related to them that may be avoided more effectively if information is provided in clinical and public health prevention and management programs.14 Eighty percent of people who suffer osteoporosis are females.1 Although more commonly seen in females, osteoporosis in males remains underdiagnosed and underreported.8 The lifetime risk for fracture may be rising in certain populations, specifically Hispanic females. According to the 2004 Surgeon General's Report on Bone Health and Osteoporosis, the prevalence of osteoporosis in Hispanic females is similar to that found in Caucasian females.
  • Osteomyelitis & Arthritis

    Osteomyelitis & Arthritis

    Osteomyelitis & Arthritis Colors of text: Definitions: Blue. Examples: Green. Important: Red. Extra explanation: Gray. It is only there to help you understand. If you feel that it didn’t add anything to you just skip it. Diseases names: Underline. 1 CONTENTS: (numbers are pages in Robbins book) ● Osteomyelitis 773 ● Pyogenic Osteomyelitis 773 ● Tuberculous Osteomyelitis 774 ● JOINTS 782 ● Infectious Arthritis 789 ● Arthritis 782 ● Osteoarthritis 782 ● Rheumatoid Arthritis 784 ● Gout 786 ● Pseudogout 789 Note: this lecture has lots of information related to microbiology, immunology, biochemistry, and pharmacology. Take it easy and try to understand the diseases to be able to link the information between the subjects. Focus on the big picture and don’t waste your precious time on small details. 2 Osteomyelitis (Robbins page 773) Osteomyelitis , Osteomyelitis (Acute and Chronic) Osteomyelitis: inflammation of the bone and bone marrow spaces, it’s common and it can start as a primary disease or secondary to systemic infections. Remember: Epiphysis is at the Ends of the bone. Primary osteomyelitis: Most cases of acute osteomyelitis are caused by bacteria. It can be seen usually in children, and the bacteria is usually transmitted by the bloodstream. Osteomyelitis is common in vertebral bones. It begins in long bone in Metaphysis then it can spread to Diaphysis especially in children. - Osteomyelitis classically manifests as an acute systemic illness, with malaise, fever, leukocytosis, and throbbing pain over the affected region. Secondary osteomyelitis: Mixed bacterial infections (aerobes and anaerobes) are responsible for osteomyelitis secondary to bone trauma. The organisms usually reach the bone through the bloodstream. Mostly, osteomyelitis is secondary to : ● Compound fractures.
  • Osteopetrosis Associated with Familial Paraplegia: Report of a Family

    Osteopetrosis Associated with Familial Paraplegia: Report of a Family

    Paraplegia (1975), 13, 143-152 OSTEOPETROSIS ASSOCIATED WITH FAMILIAL PARAPLEGIA: REPORT OF A FAMILY By SKIP JACQUES*, M.D., JOHN T. GARNER, M. D., DAVID JOHNSON, M.D. and C. HUNTER SHELDEN, M. D. Departments of Neurosurgery and Radiology, Huntington Memorial Hospital, Pasadena, Ca., and the Huntington Institute of Applied Medical Research, Pasadena, Ca., U.S.A. Abstract. A clinical analysis of three members of a family with documented osteopetrosis and familial paraplegia is presented. All patients had a long history of increased bone density and slowly progressing paraparesis of both legs. A thorough review of the literature has revealed no other cases which presented with paraplegia without spinal cord com­ pression. Although the etiologic factor or factors remain unknown, our review supports the contention that this is a distinct clinical entity. IN 1904, a German radiologist, Heinrich Albers-Schonberg, described a 26-year­ old man with multiple fractures and generalised sclerosis of the skeleton. The disease has henceforth commonly been known as Albers-Schonberg disease or marble osteopetrosis, a term first introduced by Karshner in 1922. Other eponyms are bone disease, osteosclerosis fragilis generalisata, and osteopetrosis generalisata. Approximately 300 cases had been reported in the literature by 1968. It has been generally accepted that the disease presents in two distinct forms, an infantile progressive disease and a milder form in childhood and adolescence. The two forms differ clinically and genetically. A dominant pattern of inheritance is usually seen in the benign type whereas the severe infantile form is usually inherited as a Mendelian recessive. This important distinction has not been well emphasised.
  • Who Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level

    Who Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level

    WHO SCIENTIFIC GROUP ON THE ASSESSMENT OF OSTEOPOROSIS AT PRIMARY HEALTH CARE LEVEL Summary Meeting Report Brussels, Belgium, 5-7 May 2004 1 © World Health Organization 2007 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected] ). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e- mail: [email protected] ). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader.
  • Clinical and Laboratory Considerations in Metabolic Bone Disease

    Clinical and Laboratory Considerations in Metabolic Bone Disease

    ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 5, No. 4 Copyright ® 1975, Institute for Clinical Science Clinical and Laboratory Considerations in Metabolic Bone Disease LYNWOOD H. SMITH, M.D. AND B. LAWRENCE RIGGS, M.D. Mayo Clinic and Mfiyo Foundation Rochester, MN 55901 ABSTRACT An overview of the common types of metabolic bone disease is described. When the disease is present in pure form, diagnosis is not difficult. When mixed disease is present, as may be the case, the pathophysiology involved must be clearly under­ stood for accurate diagnosis and treatment. Introduction opausal or senile osteoporosis, a disorder of unknown etiology, is the commonest form of There are many metabolic disorders that bone disease in the Western hemisphere. affect human bones; but, fortunately, the This disorder may simply represent an exag­ ways in which bones can respond are limited geration of the normal loss of bone that oc­ so that certain generalizations are valid for a curs with aging. It is estimated that the total group of diseases causing a characteristic bone loss between youth and old age is metabolic abnormality in the bone. The about 35 percent in women and somewhat common pathologic responses to metabolic less in men. The loss of bone that has oc­ bone disease include osteoporosis, os­ curred in some patients with osteoporosis is teomalacia, Paget’s disease, osteitis fibrosa not significantly different from that in age- cystica and renal osteodystrophy. These are matched normals without osteoporosis. not mutually exclusive, and it is not uncom­ In osteoporosis there is a greater propor­ mon to find more than one abnormality in tional loss of trabecular than of cortical the same patient.